Redmile Group »

Quest Diagnostics Incorporated shares owned by Redmile Group

Quarter-by-quarter ownership of Quest Diagnostics Incorporated (DGX) shares owned by Redmile Group from 13F filings

Historical chart of Redmile Group investment in Quest Diagnostics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Quest Diagnostics Incorporated held by Redmile Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Quest Diagnostics Incorporated by Redmile Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $11M 84k 133.11

More positions owned by Redmile Group

Krystal Biotech (KRYS)
Amicus Therapeutics (FOLD)
Immunome (IMNM)
Scholar Rock Hldg Corp (SRRK)
Fate Therapeutics (FATE)
Regenxbio Inc equity us cm (RGNX)
Deciphera Pharmaceuticals (DCPH)
Kymera Therapeutics (KYMR)
Adc Therapeutics Sa SHS (ADCT)
Stoke Therapeutics (STOK)
Augmedix (AUGX)
Nurix Therapeutics (NRIX)
Biohaven (BHVN)
Beam Therapeutics (BEAM)
Zymeworks Del (ZYME)

View all positions for Redmile Group

Top funds holding Quest Diagnostics Incorporated

Vanguard Group
BlackRock
Victory Capital Management
American Century Companies
Wellington Management Company
Geode Capital Management
Davis Selected Advisers
Grantham, Mayo, Van Otterloo & Co
Dimensional Fund Advisors
Morgan Stanley
Goldman Sachs Group
Jpmorgan Chase & Co
Wells Fargo & Company
Fiduciary Management
FMR

View all funds holding Quest Diagnostics Incorporated